Published on January 28, 2010 at 7:15 AM
Research and Markets (http://www.researchandmarkets.com/research/6db2e1/head_and_neck_canc)
has announced the addition of the "Head
and Neck Cancer Drug Pipeline Update 2010" report to their offering.
“Head
and Neck Cancer Drug Pipeline Update 2010”
There are today 111 companies plus partners developing 122 drugs
targeting head and neck cancer in active development. In addition, the
accumulated number of ceased drugs over the last years amount to another
33 drugs. Head And Neck Cancer Drug Pipeline Update lists all drugs and
gives you a progress analysis on each one of them. Identified drugs are
linked to 92 different targets. These targets are further categorized on
the CD-ROM by 34 classifications of molecular function and with pathway
referrals to BioCarta, KEGG and NetPath. Figures in brackets are
comparative data from last year.
Find and sort drugs by twelve different parameters plus free text search
field. Our dynamic report generator lets you with ease and speed
generate html reports directly in your web browser, whether it is a
single drug profile or an entire search you want have a report of.
How May Drug Pipeline Update Be of Use?
-
Show investors/board/management that you are right on top of drug
development progress in your therapeutic area.
-
Find competitors, collaborations partners, candidates etc.
-
Jump start competitive drug intelligence operations
-
Excellent starting point for world wide benchmarking
-
Compare portfolio and therapy focus with your peers
-
Speed up pro-active in-/out licensing strategy work
-
Fast and easy way of tracking drugs using search engines; just one
click from inside the application and you may search the World Wide
Web and PubMed for any drug.
http://www.researchandmarkets.com